This research demonstrates an automated workflow improving metabolite extraction in blood samples, indicating enhanced NMR applications in precision medicine.
Nuclear magnetic resonance (NMR) spectroscopy is a cornerstone of metabolomics and clinical bioanalysis; yet, its routine clinical adoption is limited by challenges in quality control (QC) and spectral interpretation. In blood-based NMR studies, ethylenediaminetetraacetic acid (EDTA) and its metal complexes are a major source of spectral interference, obscuring endogenous metabolites while increasing the analytical complexity. Here, we introduce a fully automated cheminformatics platform that enables EDTA-aware QC and the quantitative extraction of metal ion information while preserving metabolic integrity. Using large plasma and serum cohorts acquired at 500 and 600 MHz, we establish a multicenter-validated workflow for accurate quantification of calcium (Ca²⁺), magnesium (Mg²⁺), and zinc (Zn²⁺) directly from routine ¹H NMR spectra (R² > 0.9 versus clinical and spectrometric assays). The platform harmonizes data sets across instruments and cohorts through automated baseline reconstruction. Application to a large breast cancer cohort reveals a stage-dependent decline in circulating Zn²⁺, consistent with disrupted zinc homeostasis in invasive disease. This work bridges metabolomics and metallomics, advancing the translational utility of NMR in precision medicine.
No takes yet. Share an insight, caveat, or question.
Theodorou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: